Skip to main navigation Skip to search Skip to main content

Practical Compendium of Antiarrhythmic Drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology

  • Jose L Merino*
  • , Juan Tamargo
  • , Carina Blomström-Lundqvist
  • , Giuseppe Boriani
  • , Harry J G M Crijns
  • , Dobromir Dobrev
  • , Andreas Goette
  • , Stefan H Hohnloser
  • , Gerald V Naccarelli
  • , James A Reiffel
  • , Jacob Tfelt-Hansen
  • , Marcel Martínez Cossiani
  • , A John Camm
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The European Heart Rhythm Association Practical Compendium of Anti-arrhythmic Drugs (AADs) offers advice on these drugs, focusing on their clinical use and the global impact of cardiac arrhythmias. This document aims to provide practical instructions to clinicians in arrhythmia management through pharmacological strategies. The compendium highlights persistent challenges in arrhythmia treatment, including clinical constraints, procedural risks, and the complexity of certain arrhythmias. Notably, atrial fibrillation is highly prevalent, and the demand for invasive treatment often surpasses the capacity of existing healthcare systems. As a result, pharmacological management remains essential. This is particularly relevant for patients with cardiac implantable electronic devices or channelopathies, where ablation is often not a suitable option. Anti-arrhythmic drugs play a pivotal role in these scenarios. The compendium introduces the ABC framework for AAD therapy: A (Appropriate therapy), for patients in whom AADs are the best therapeutic option; B (Backup therapy), as adjunctive treatment to invasive procedures, such as catheter ablation; and C (Complementary therapy), in combination with other therapies. The document provides detailed insights into the mechanisms of action, efficacy, safety profiles, and drug interactions of each class of AADs. Additionally, the compendium covers practical considerations, including initiation, combination strategies, monitoring, follow-up, special populations, and adverse effect management, with an emphasis on pro-arrhythmia risk mitigation. It also explores the integration of AADs with other therapeutic modalities, promoting a synergistic approach to optimize patient outcomes. In summary, this compendium serves as an indispensable resource for clinicians, offering practical advice and evidence-based insights to navigate the complexities of arrhythmia management effectively.

Original languageEnglish
Article numbereuaf076
JournalEP Europace
Volume27
Issue number8
Early online date30 Mar 2025
DOIs
Publication statusPublished - 4 Aug 2025

Keywords

  • adverse drug reactions
  • antiarrhythmic drug combinations
  • antiarrhythmic drugs
  • arrhythmia
  • atrial fibrillation
  • drug interactions
  • mechanisms
  • pharmacology
  • ventricular arrhythmias

Fingerprint

Dive into the research topics of 'Practical Compendium of Antiarrhythmic Drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology'. Together they form a unique fingerprint.

Cite this